Chongqing Taiji Industry (Group) Co.Ltd(600129) the outline of the “14th five year plan” (2021-2025) was released on the evening of December 31, 2021. The company will unswervingly focus on the main business of medicine and health. The core main line is to give full play to the brand influence of the well-known trademark of “Taiji” and the century old brand of “TongJunGe”, and fully tap the market value of traditional Chinese medicine, brand products and classic famous parties, Create a modern traditional Chinese medicine with scientific and technological innovation, intelligent manufacturing and other advantages. Parallel auxiliary line is to build a chemical and biological drug production base characterized by hemp essence medicine; Build a leading pharmaceutical business enterprise in Sichuan and Chongqing. Through endogenous development and extension expansion, Chongqing Taiji Industry (Group) Co.Ltd(600129) strive to achieve an operating revenue of 50 billion yuan at the end of the 14th five year plan, with a net profit margin not lower than the average level of the pharmaceutical industry, and strive to become a world-class traditional Chinese medicine enterprise.
In terms of specific strategy, the company will focus on innovative drug R & D and secondary development of main varieties to strengthen key categories; Innovate the marketing mechanism and mode to ensure the continuous and rapid growth of sales; Control and manage the resources of traditional Chinese medicine; Build a digital modern traditional Chinese medicine manufacturing system; Build a leading pharmaceutical business enterprise in Sichuan and Chongqing; Carry forward the culture of traditional Chinese medicine and shape the leading brand image of traditional Chinese medicine; Create a Tai Chi featured health preservation platform; Standardize governance and improve the overall organizational strength of the company; Improve the level of financial operation and capital operation and promote the great leap forward development of the company.
In the plan, Chongqing Taiji Industry (Group) Co.Ltd(600129) lists scientific and technological innovation as the first of the enterprise development strategy and as an important means to promote the high-quality development of the enterprise.
In terms of traditional Chinese medicine resources, the company will scientifically arrange the “double bases” (medicine planting and processing bases) that meet the GaCp specifications and the requirements of whole process traceability, and take the initiative from the source of traditional Chinese medicine resources. Give full play to the advantages of resources and market research and judgment, and implement large variety management. Actively promote the industrialization of artificial tending Cordyceps. At the same time, focus on Sichuan and Chongqing, actively transform, accelerate the construction of a global digital integrated marketing platform, accelerate terminal layout, and build a regional pharmaceutical business leader.
In terms of great health preservation platform, guided by “healthy China”, with the help of e-commerce mode, upstream and downstream integration and import and export, the company strives to build a Tai Chi great health preservation system with the connotation of traditional Chinese medicine health preservation culture, and become a new growth point of Chongqing Taiji Industry (Group) Co.Ltd(600129) leapfrog development. The company will also further enrich Taiji health products. With the help of Taiji’s rich tonic product resources and the advantageous imported resources of Sinopharm group, the company will establish and improve tonic proprietary Chinese medicine, medicinal and food homologous traditional Chinese medicine decoction pieces and formula particles, intelligent wearable medical equipment, health food, special medical food, traditional Chinese medicine daily chemicals Large health preservation product libraries such as light medical beauty products and biological health products.
In terms of capital operation, Chongqing Taiji Industry (Group) Co.Ltd(600129) will promote capital and share increase, introduce development funds and reduce asset liability ratio; Actively seek mergers and acquisitions of outstanding enterprises in the industry. Introduce strategic investors, implement capital market refinancing, and actively promote the R & D of strategic varieties, the upgrading of intelligent manufacturing and the M & A of target enterprises. During the 14th Five Year Plan period, we will complete the optimal disposal and rational operation of “two non” enterprises (non main business and enterprises with strong non-profit ability), idle or low benefit assets.
(China Securities Journal · China Securities Network)
